If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
559.00    3.00 (0.54%)
Bid:
556.50
Ask:
557.00
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

8 Jul 2015 14:52

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) announces that it was informed yesterday that on 7 July 2015, a grant of options and awards over the Company’s ordinary shares of 25 pence each in the capital of the Company (“Shares”) was made to Persons Discharging Managerial Responsibilities (“PDMR”) and to an Executive Director as follows:

1. PDMRs

Name Role Number of Shares subject to option* Number of Shares subject to award*
Rowan Adams PDMR 35,000 -
Joan Braca PDMR - 90,000
Robert Gibber PDMR 110,000 -
Rob Luijten PDMR 80,000 -
Gabrielle Parisse PDMR - 70,000
Pierre Schoumacher PDMR - 70,000

* Options are generally granted to UK residents and awards to non-UK residents.

The above options and awards will only vest to the extent that certain Company-based financial performance criteria are satisfied over a performance period which runs from 1 April 2015 to 31 March 2016. No consideration is payable for the grant or exercise of the options or awards. Options and awards will be subject to a 12-month deferral period and continued employment to 31 March 2017.

2. Nick Hampton

As explained on pages 71 and 72 of the Company’s Annual Report 2015, Nick Hampton, Chief Financial Officer, was granted an award in the form of a nil cost option over 121,781 ordinary shares of 25 pence each in the capital of the Company (the “Award”).

The Award was granted in connection with Mr Hampton’s recruitment as Chief Financial Officer and is intended to honour the agreement (announced on 24 June 2014) to compensate him for incentive awards that he forfeited at his previous employer.

The Award which is within the shareholder approved remuneration policy (for recruitment) has been granted following consultation with major shareholders. As a condition of the grant of the Award, Mr Hampton has surrendered the compensatory Award C that was granted to him on 18 November 2014 with a face value at the time of £1.44m.

The Award will be available for exercise by Mr Hampton after 31 March 2017.

Following the grant of the Award, the incentive arrangements relating to the recruitment of Mr Hampton are as follows:

Award name Date of grant Number of Shares subject to option Vesting Date
Award A 18/11/2014 96,681 01/09/15
Award B 18/11/2014 96,680 01/09/16
Award C – replacement 07/07/2015 121,781 After 31/03/17

All the above transactions took place in London.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FCA’s Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

8 July 2015

Note:

Extract from the announcement issued on 24 June 2014:

To compensate Nick for incentive awards that he will forfeit at PepsiCo Europe, Tate & Lyle will make him a one-off Restricted Stock Award (RSA) of £1,200,000 worth of shares in Tate & Lyle (delivered in two equal tranches on the first and second anniversaries of his employment with Tate & Lyle subject to achievement of performance conditions) (Award A and B). In addition, he will receive a PSP award in 2014 of £1,440,000 worth of shares in Tate & Lyle (Award C). The foregoing RSA and PSP award will be subject to forfeiture/repayment if he ceases to be employed in the first 36 months of employment due to his resignation or dismissal for cause.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150708005829/en/

Copyright Business Wire 2015

Date   Source Headline
2nd Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025
5th Jun 20252:00 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:30 pmRNSTotal Voting Rights
28th May 202512:00 pmRNSDirector/PDMR Shareholding
27th May 202512:00 pmRNSDirector/PDMR Shareholding
23rd May 202510:00 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSFinal Results
14th May 20259:00 amRNSHolding(s) in Company
1st May 20253:00 pmRNSHolding(s) in Company
29th Apr 20253:30 pmRNSHolding(s) in Company
28th Apr 20255:15 pmRNSHolding(s) in Company
24th Apr 202512:00 pmRNSHolding(s) in Company
15th Apr 20257:00 amRNSIntegration update and pre-close statement
27th Mar 20257:00 amRNSDirectorate Change
14th Mar 202510:05 amRNSDirectorate declaration
11th Mar 20253:00 pmRNSHolding(s) in Company
5th Mar 202511:30 amRNSDirector/PDMR Shareholding
28th Feb 20254:30 pmRNSHolding(s) in Company
28th Feb 202510:15 amRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSAdditional Listing
20th Feb 20251:42 pmRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSTrading Statement
4th Feb 20257:05 amRNSDirector Declaration
3rd Feb 20253:30 pmRNSTotal Voting Rights
23rd Jan 20255:30 pmRNSIssue of Debt
9th Jan 20255:54 pmRNSCompletion of Share Buyback Programme
9th Jan 20255:45 pmRNSTransaction in Own Shares
8th Jan 20255:17 pmRNSTransaction in Own Shares
8th Jan 20252:02 pmRNSDirector/PDMR Shareholding
7th Jan 20255:31 pmRNSTransaction in Own Shares
6th Jan 20256:10 pmRNSTransaction in Own Shares
6th Jan 20252:00 pmRNSDirectorate Change
3rd Jan 20255:28 pmRNSTransaction in Own Shares
2nd Jan 20255:20 pmRNSTransaction in Own Shares
2nd Jan 20252:10 pmRNSBlock listing Interim Review
2nd Jan 20252:00 pmRNSTotal Voting Rights
30th Dec 20245:36 pmRNSTransaction in Own Shares
27th Dec 20245:15 pmRNSTransaction in Own Shares
23rd Dec 20245:26 pmRNSTransaction in Own Shares
20th Dec 20245:31 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.